Literature DB >> 26235375

T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: association with clinical type and severity.

Mona A Atwa1, Nahed Youssef2, Nervana M Bayoumy3.   

Abstract

BACKGROUND: Alopecia areata (AA) is an organ-specific autoimmune disease characterized by T-cell infiltrates and cytokine production. T-helper 17 (Th17) cells are crucially involved in the pathogenesis of autoimmune diseases.
OBJECTIVES: Our aim was to assess the association of Th17 with AA. We examined interleukin (IL)-17, IL-21, IL-22, IL-6, and tumor necrosis factor-alpha (TNF-α) levels in the serum of patients with AA and studied their association with clinical type and severity of AA. SUBJECTS AND METHODS: The serum concentrations of IL-17, IL-21, IL-22, IL-6, and TNF-α were measured in 47 patients with AA and 40 healthy controls. The clinical type of AA was determined, and the severity of hair loss was assessed in accordance with the Alopecia Areata Investigational Assessment Guideline criteria.
RESULTS: The serum concentrations of IL-17, IL-21, IL-22, IL-6, and TNF-α were significantly higher in patients with AA as compared with healthy controls (mean: IL-17 33.23 ± 11.58 vs. 4.62 ± 1.88 pg/ml; P = 0.000, IL-21 62.10 ± 6.11 vs. 48.38 ± 3.31 pg/ml; P = 0.000, IL-22 19.27 ± 3.36 vs. 7.09 ± 1.62 pg/ml; P = 0.000, IL-6 17.18 ± 3.08 vs. 4.59 ± 1.66 pg/ml; P = 0.000, TNF-α 19.94 ± 3.59 vs. 9.95 ± 2.42 pg/ml; P = 0.000, respectively). There were significant positive correlations between serum IL-17, TNF-α, and disease severity. There was also significant positive correlation between serum IL-22 and duration of AA.
CONCLUSION: Our results showed high serum levels of Th17 cytokines among patients with AA that may suggest a functional role of these cytokines in the pathogenesis of this important skin disease. It could also provide the rationale for new treatment strategies in AA.
© 2015 The International Society of Dermatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26235375     DOI: 10.1111/ijd.12808

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  20 in total

1.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

3.  Two Cases of Cutaneous Adverse Effects Induced by Tumor Necrosis Factor-Alpha Inhibitors.

Authors:  Ena Masukawa; Yoshiaki Matsushima; Koji Habe; Keiichi Yamanaka
Journal:  Case Rep Dermatol       Date:  2021-04-19

Review 4.  The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.

Authors:  Yael Renert-Yuval; Emma Guttman-Yassky
Journal:  Adv Ther       Date:  2017-06-23       Impact factor: 3.845

5.  Extreme Phenotype of Epidermal Growth Factor Receptor Inhibitor-induced Destructive Folliculitis.

Authors:  Florian Anzengruber; Barbara Meier; Julia-Tatjana Maul; Katrin Kerl; Lars E French; Alexander A Navarini
Journal:  Int J Trichology       Date:  2016 Oct-Dec

6.  Fibroblast cell-based therapy prevents induction of alopecia areata in an experimental model.

Authors:  Reza B Jalili; Ruhangiz T Kilani; Yunyuan Li; Mohsen Khosravi-Maharlooie; Layla Nabai; Eddy Hsi Chun Wang; Kevin J McElwee; Aziz Ghahary
Journal:  Cell Transplant       Date:  2018-06-05       Impact factor: 4.064

7.  Serum concentrations of selected proinflammatory cytokines in children with alopecia areata.

Authors:  Katarzyna Tabara; Magdalena Kozłowska; Anna Jędrowiak; Wojciech Bienias; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

Review 8.  Learning From Success and Failure: Biologics for Non-approved Skin Diseases.

Authors:  Reinhart Speeckaert; Jo Lambert; Nanja van Geel
Journal:  Front Immunol       Date:  2019-08-08       Impact factor: 7.561

Review 9.  IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.

Authors:  Nicoletta Bernardini; Nevena Skroza; Ersilia Tolino; Alessandra Mambrin; Alessia Anzalone; Veronica Balduzzi; Daniela Colapietra; Anna Marchesiello; Simone Michelini; Ilaria Proietti; Concetta Potenza
Journal:  Int J Dermatol       Date:  2019-10-30       Impact factor: 2.736

10.  Increased Serum Level and High Tissue Immunoexpression of Interleukin 17 in Cutaneous Lichen Planus: A Novel Therapeutic Target for Recalcitrant Cases?

Authors:  Magdalena Żychowska; Aleksandra Batycka-Baran; Wojciech Baran
Journal:  Dis Markers       Date:  2020-07-24       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.